The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Early drug development in advanced gynecologic cancer based on genetic tumor profiling.
 
Ana C. Garrido-Castro
No Relationships to Disclose
 
Guillem Argilés
Speakers' Bureau - Bayer; Merck Serono
Travel, Accommodations, Expenses - Amgen; Merck Serono; Roche Pharma AG; Sanofi
 
Debora Moreno
No Relationships to Disclose
 
Marta Vilaro
No Relationships to Disclose
 
Victor Rodriguez-Freixinos
No Relationships to Disclose
 
Teresa Macarulla
No Relationships to Disclose
 
Cristina Cruz
No Relationships to Disclose
 
Analia Azaro
No Relationships to Disclose
 
Elena Élez
No Relationships to Disclose
 
Maria Alsina
No Relationships to Disclose
 
Jose Manuel Perez-Garcia
No Relationships to Disclose
 
Jose Jimenez
No Relationships to Disclose
 
Paolo Nuciforo
Consulting or Advisory Role - Debiopharm Group; Novartis; Samsung
 
Ana Vivancos
Consulting or Advisory Role - Novartis
 
Joan Seoane
No Relationships to Disclose
 
Jose Maria Del Campo
Speakers' Bureau - Boehringer Ingelheim; MSD Oncology; PharmaMar; Roche
 
Jordi Rodón
Consulting or Advisory Role - Leti Pharma; Lilly; Novartis; Orion; SERVIER
 
Josep Tabernero
Consulting or Advisory Role - Amgen; Celgene; Chugai Pharma; ImClone Systems; Lilly; Merck KGaA; Millennium; Novartis; Roche/Genentech; Sanofi; Symphony Evolution; Taiho Pharmaceutical
 
Ana Oaknin
Consulting or Advisory Role - AstraZeneca; Roche Pharma AG